Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01265433
What this trial is testing

Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy

Who this might be right for
Malignant Pleural Mesothelioma
Sellas Life Sciences Group 41
Testing effectiveness (Phase 2)UnknownNCT03732547
What this trial is testing

Study of PolyIC and PD-1 mAb in Subjects With Unresectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Second Affiliated Hospital, Zhejiang University, School of Medicine 60
Testing effectiveness (Phase 2)Study completedNCT01523847
What this trial is testing

A Multi-centre Study of MBVD in Elderly and/or Cardiopathic Patients Affected by Hodgkin's Lymphoma (HL)

Who this might be right for
Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS 50
Testing effectiveness (Phase 2)Study completedNCT00615758
What this trial is testing

Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 50
Testing effectiveness (Phase 2)Study completedNCT01521585
What this trial is testing

A Phase II Safety and Tolerability Study With SEN0014196

Who this might be right for
Huntington's Disease
Siena Biotech S.p.A. 144
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07178678
What this trial is testing

Evaluation of the Safety and Efficacy of NeuroEPO in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild Alzheimer's DiseaseModerate Alzheimer's Disease
University of Saskatchewan 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT04021108
What this trial is testing

Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)

Who this might be right for
Gastroesophageal Adenocarcinoma
Weill Medical College of Cornell University 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT03008408
What this trial is testing

A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma

Who this might be right for
Recurrent Endometrial CarcinomaRecurrent Endometrial Endometrioid AdenocarcinomaRefractory Endometrial Carcinoma+10 more
M.D. Anderson Cancer Center 90
Early research (Phase 1)Study completedNCT05255276
What this trial is testing

PK Study to Assess Drug-drug Interaction Between Sitravatinib and a P-gp Inducer and an Inhibitor.

Who this might be right for
Healthy Adults
Mirati Therapeutics Inc. 36
Testing effectiveness (Phase 2)Looking for participantsNCT04150640
What this trial is testing

Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma

Who this might be right for
Esophageal AdenocarcinomaGastric Adenocarcinoma
University of Wisconsin, Madison 52
Testing effectiveness (Phase 2)Study completedNCT00193050
What this trial is testing

Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 110
Testing effectiveness (Phase 2)Study completedNCT00425191
What this trial is testing

Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.

Who this might be right for
Non-small Cell Lung Cancer
Sanofi 165
Testing effectiveness (Phase 2)UnknownNCT00964626
What this trial is testing

Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
Russian Academy of Medical Sciences 60
Testing effectiveness (Phase 2)Ended earlyNCT02299635
What this trial is testing

A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch Alterations

Who this might be right for
Triple Negative Breast Neoplasms
Pfizer 19
Testing effectiveness (Phase 2)Study completedNCT00534625
What this trial is testing

Assessment of PFT, Safety, and PK of Zileuton Injection in Asthma Patients

Who this might be right for
Asthma
Critical Therapeutics 36
Not applicableLooking for participantsNCT07037576
What this trial is testing

Efficacy and Safety of Prepectoral Prosthesis Immediate One-Stage Breast Reconstruction Versus Two-Stage Expander/Prosthesis Reconstruction in Postoperative Adjuvant Radiotherapy Breast Cancer Patients: A Prospective, Single-Center, Cohort Study

Who this might be right for
Breast Cancer Patients
Henan Cancer Hospital 104
Testing effectiveness (Phase 2)Study completedNCT00391989
What this trial is testing

Treatment of Adult Ph+ LAL With BMS-354825

Who this might be right for
Lymphoblastic Leukemia, Acute
Gruppo Italiano Malattie EMatologiche dell'Adulto 53
Testing effectiveness (Phase 2)Ended earlyNCT03367689
What this trial is testing

A Two-stage Simon Design Phase II Study for Non-BRCA MBC Patients With HRD Treated With Olaparib Single Agent

Who this might be right for
Breast Cancer
MedSIR 7
Testing effectiveness (Phase 2)Study completedNCT01643668
What this trial is testing

Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Massachusetts General Hospital 34
Post-approval studies (Phase 4)Active Not RecruitingNCT05983068
What this trial is testing

Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis

Who this might be right for
Dermatitis Atopic
Sanofi 48
Next Page